Managing Toxicities from Chronic Myeloid Leukemia Treatment
2 Visninger
• 07/08/23
0
0
Indlejre
administrator
Abonnenter
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer